Ligand validation:7HII

XJV: imidazolidin-2-one

XJV is a Ligand Of Interest in 7HII designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7HII_XJV_D_206	52%	94%	0.122	0.88	0.13	0.29	-	-	0	0	100%	0.55
7HII_XJV_B_203	35%	94%	0.189	0.875	0.14	0.29	-	-	0	0	100%	0.52
7HII_XJV_A_207	10%	94%	0.206	0.703	0.13	0.29	-	-	0	0	100%	0.52
7H8C_XJV_D_206	68%	93%	0.117	0.928	0.17	0.3	-	-	0	0	100%	0.68
7HIH_XJV_D_205	62%	94%	0.1	0.89	0.15	0.29	-	-	0	0	100%	0.64
7HIJ_XJV_A_208	56%	94%	0.111	0.881	0.15	0.28	-	-	0	0	100%	0.65
7HIK_XJV_A_208	42%	94%	0.137	0.855	0.15	0.29	-	-	0	0	100%	0.52
5S81_XJV_B_507	55%	16%	0.136	0.905	1.95	1.76	3	2	0	0	100%	0.58
7H4R_XJV_A_201	55%	94%	0.15	0.918	0.17	0.25	-	-	0	0	100%	0.54

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.